The FDA released a new rule yesterday regarding the labeling of prescriptions and biological products which affect pregnancy, lactation and reproduction. From the press release: “The final rule replaces the current product letter categories – A, B, C, D and X – used to classify the risks of using prescription drugs during pregnancy with three … Continue reading FDA Sets New Standards for Labels